McEntagart Meriel, Parsons Gretchen, Buj-Bello Anna, Biancalana Valérie, Fenton Iain, Little Mark, Krawczak Michael, Thomas Nick, Herman Gail, Clarke Angus, Wallgren-Pettersson Carina
Institute of Medical Genetics, University of Wales College of Medicine, Cardiff, UK.
Neuromuscul Disord. 2002 Dec;12(10):939-46. doi: 10.1016/s0960-8966(02)00153-0.
X-linked myotubular myopathy is a severe congenital myopathy that presents in the neonatal period with profound hypotonia and an inability to establish spontaneous respiration. Usually death occurs in infancy from respiratory failure. However, there is phenotypic variability; a number of affected boys have achieved respiratory independence and become ambulatory. Disease-causing mutations have been identified throughout the MTM1 gene on Xq28. MTM1 encodes the protein myotubularin, which is expressed ubiquitously. The main objectives of this study were to establish whether the nature or site of the mutation in the MTM1 gene could predict severity of the disease and to investigate whether early intensive clinical intervention facilitated survival until spontaneous improvement occurred. An association was demonstrated between the presence of a non-truncating mutation of the MTM1 gene and the mild phenotype. However, many non-truncating mutations were also seen in association with the severe phenotype and these were not confined to recognized functional domains of the protein. This suggests that the use of mutation analysis to predict prognosis in the early period following diagnosis is limited. Unexpectedly, over 50 patients surviving for more than 1 year were identified in this study. Further information obtained on 40 of these cases revealed that 50% were receiving 24-h ventilatory support, while 27% were ventilated at night only. The high survival rate for this disorder therefore reflects intensive medical intervention without which the majority of these boys would not survive.
X连锁性肌管性肌病是一种严重的先天性肌病,在新生儿期表现为严重的肌张力减退且无法自主呼吸。通常在婴儿期因呼吸衰竭而死亡。然而,存在表型变异性;一些患病男孩实现了呼吸自主并能够行走。在位于Xq28的MTM1基因中已鉴定出致病突变。MTM1编码肌管素蛋白,该蛋白在全身表达。本研究的主要目的是确定MTM1基因突变的性质或位点是否能够预测疾病的严重程度,并调查早期强化临床干预是否有助于存活直至出现自发改善。已证实MTM1基因存在非截短突变与轻度表型之间存在关联。然而,许多非截短突变也与严重表型相关,并且这些突变并不局限于该蛋白公认的功能域。这表明在诊断后的早期使用突变分析来预测预后是有限的。出乎意料的是,本研究中鉴定出50多名存活超过1年的患者。对其中40例病例进一步获得的信息显示,50%的患者接受24小时通气支持,而27%的患者仅在夜间通气。因此,这种疾病的高存活率反映了强化医疗干预,没有这种干预,这些男孩中的大多数将无法存活。